| WOMBAT: world of molecular bioactivity M Olah, M Mracec, L Ostopovici, R Rad, A Bora, N Hadaruga, I Olah, ... Chemoinformatics in drug discovery 223239, 2004 | 173 | 2004 |
| WOMBAT: world of molecular bioactivity M Olah, M Mracec, L Ostopovici, R Rad, A Bora, N Hadaruga, I Olah, ... Chemoinformatics in drug discovery 223239, 2004 | 173 | 2004 |
| Modulation of bitter taste perception by a small molecule hTAS2R antagonist JP Slack, A Brockhoff, C Batram, S Menzel, C Sonnabend, S Born, ... Current Biology 20 (12), 1104-1109, 2010 | 170 | 2010 |
| DrugCentral 2021 supports drug discovery and repositioning S Avram, CG Bologa, J Holmes, G Bocci, TB Wilson, DT Nguyen, ... Nucleic acids research 49 (D1), D1160-D1169, 2021 | 156 | 2021 |
| A crowdsourcing evaluation of the NIH chemical probes TI Oprea, CG Bologa, S Boyer, RF Curpan, RC Glen, AL Hopkins, ... Nature chemical biology 5 (7), 441-447, 2009 | 139 | 2009 |
| Lead-like, drug-like or “Pub-like”: how different are they? TI Oprea, TK Allu, DC Fara, RF Rad, L Ostopovici, CG Bologa Journal of Computer-Aided Molecular Design 21, 113-119, 2007 | 130 | 2007 |
| WOMBAT and WOMBAT‐PK: bioactivity databases for lead and drug discovery M Olah, R Rad, L Ostopovici, A Bora, N Hadaruga, D Hadaruga, ... Chemical biology: from small molecules to systems biology and drug design 1 …, 2007 | 120 | 2007 |
| Real-time analysis of conformation-sensitive antibody binding provides new insights into integrin conformational regulation A Chigaev, A Waller, O Amit, L Halip, CG Bologa, LA Sklar Journal of Biological Chemistry 284 (21), 14337-14346, 2009 | 58 | 2009 |
| Structural determinants of the alpha2 adrenoceptor subtype selectivity L Ostopovici-Halip, R Curpăn, M Mracec, CG Bologa Journal of Molecular Graphics and Modelling 29 (8), 1030-1038, 2011 | 29 | 2011 |
| Conformational mAb as a tool for integrin ligand discovery BH Njus, A Chigaev, A Waller, D Wlodek, L Ostopovici-Halip, O Ursu, ... Assay and drug development technologies 7 (5), 507-515, 2009 | 27 | 2009 |
| FRET detection of lymphocyte function–associated antigen-1 conformational extension A Chigaev, Y Smagley, MK Haynes, O Ursu, CG Bologa, L Halip, T Oprea, ... Molecular biology of the cell 26 (1), 43-54, 2015 | 23 | 2015 |
| DrugCentral 2023 extends human clinical data and integrates veterinary drugs S Avram, TB Wilson, R Curpan, L Halip, A Borota, A Bora, CG Bologa, ... Nucleic acids research 51 (D1), D1276-D1287, 2023 | 20 | 2023 |
| Modeling kinase inhibition using highly confident data sets S Avram, A Bora, L Halip, R Curpan Journal of Chemical Information and Modeling 58 (5), 957-967, 2018 | 19 | 2018 |
| On the propagation of errors in the QSAR literature TI Oprea, M Olah, L Ostopovici, R Rad, M Mracec EuroQSAR, 314-315, 2002 | 18 | 2002 |
| Three small molecule pan activator families of Ras-related GTPases Z Surviladze, O Ursu, F Miscioscia, R Curpan, L Halip, C Bologa, T Oprea, ... Probe Reports from the NIH Molecular Libraries Program [Internet], 2010 | 17 | 2010 |
| Off-patent drug repositioning S Avram, R Curpan, L Halip, A Bora, TI Oprea Journal of chemical information and modeling 60 (12), 5746-5753, 2020 | 16 | 2020 |
| Novel drug targets in 2021. S Avram, L Halip, R Curpan, TI Oprea Nature reviews. Drug discovery 21 (5), 328-328, 2022 | 15 | 2022 |
| Novel drug targets in 2019. S Avram, L Halip, R Curpan, TI Oprea Nature Reviews Drug Discovery 19 (5), 300-301, 2020 | 14 | 2020 |
| Synthesis, structure and toxicity evaluation of ethanolamine nitro/chloronitrobenzoates: a combined experimental and theoretical study M Crisan, L Halip, P Bourosh, SA Chicu, Y Chumakov Chemistry Central Journal 11, 1-10, 2017 | 14 | 2017 |
| A QSAR study using MTD method and Dragon descriptors for a series of selective ligands of α2C adrenoceptor A Borota, M Mracec, A Gruia, R Rad-Curpăn, L Ostopovici-Halip, ... European journal of medicinal chemistry 46 (3), 877-884, 2011 | 12 | 2011 |
